Skeel's Handbook of Cancer Therapy

• Other Authors: Khleif, Samir N. (Editor), Rixe, Olivier (Editor), Skeel, Roland T. (Editor)
• Format: Manuscript Book
• Language: English
• Published: Philadelphia Wolters Kluwer Health 2016
• Edition: NINTH EDITION
• Subjects: Neoplasms > Handbook > therapy; Antineoplastic Agents > Handbook > administration & dosage
• Online Access: Click Here to View Status and Holdings.
• Item Description: Preceded by Handbook of cancer chemotherapy / edited by Roland T. Skeel, Samir N. Khleif. Eighth edition. 2011
• Physical Description: xiii, 884 pages illustrations 20 cm
• Bibliography: Includes bibliographical references and index
• ISBN: 9781496305558; 1496305558

For more than 30 years, Skeel's Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy ) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including innovations in immunotherapy, oncology genomics, and molecular targeted therapy. An invaluable reference for all levels of physicians, nurses, and allied health professionals who provide care to cancer patients, this bestselling guide combines the most current rationale and the details necessary to safely administer pharmacologic therapy, offering a balanced synthesis between science and clinical practice. A new chapter on the Biologic Basis of Molecular Targeted Therapy , as well as a state-of-the-art review of the current development and use of novel immunotherapeutics , bring you up to date with the rationale and use of these newer agents in cancer treatment. Completely updated throughout to reflect current best practices, including primary indications, usual dosage and schedule, special precautions, and expected toxicities for dozens of new drugs and biologic agents. New contributors provide a fresh perspective on timely topics in cancer treatment and care. An updated section on supportive care reflects this essential aspect of the oncology team's focus. Regularly updated Inkling content keeps you current with drug profiles and new immunotherapy advances.